Therefore, the aim of this study was to determine the efficacy, safety, and impact on vitamin D metabolism of short-term rifampin treatment in children with mild hypercalcemia due to HCINF3 and compare this with the response in a control patient with HCINF1. The gene discussed is CYP24A1; the disease is hypercalcemia disease.